MYRIAD ASSET MANAGEMENT US LP – Vertex Pharmaceuticals Incorporated Transaction History
MYRIAD ASSET MANAGEMENT US LP portfolio value:
$0
portfolio value
MYRIAD ASSET MANAGEMENT US LP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -12.6K shares | -3.55M | $289.54 | 0 |
| Q2 2022 | share | Increase | 0.00% | 12.6K shares | 3.55M | $281.79 | 12.6K |